First-trimester prediction of hypertensive disorders in pregnancy
- PMID: 19273739
- DOI: 10.1161/HYPERTENSIONAHA.108.127977
First-trimester prediction of hypertensive disorders in pregnancy
Abstract
This study aimed to establish a method of screening for pregnancy hypertension by a combination of maternal variables, including mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor in early pregnancy. The base-cohort population constituted of 7797 singleton pregnancies, including 34 case subjects who developed preeclampsia (PE) requiring delivery before 34 weeks (early PE) and 123 with late PE, 136 with gestational hypertension, and 7504 cases subjects (96.3%) who were unaffected by PE or gestational hypertension. Maternal history, uterine artery pulsatility index, mean arterial pressure, and pregnancy-associated plasma protein-A were recorded in all of the cases in the base cohort, but placental growth factor was measured only in the case-control population of 209 cases who developed hypertensive disorders and 418 controls. In each case the measured mean arterial pressure, uterine artery pulsatility index, pregnancy-associated plasma protein-A, and placental growth factor were converted to a multiple of the expected median (MoM) after correction for maternal characteristics found to affect the measurements in the unaffected group. Early PE and late PE were associated with increased mean arterial pressure (1.15 MoM and 1.08 MoM) and uterine artery pulsatility index (1.53 MoM and 1.23 MoM) and decreased pregnancy-associated plasma protein-A (0.53 MoM and 0.93 MoM) and placental growth factor (0.61 MoM and 0.83 MoM). Logistic regression analysis was used to derive algorithms for the prediction of hypertensive disorders. It was estimated that, with the algorithm for early PE, 93.1%, 35.7%, and 18.3% of early PE, late PE, and gestational hypertension, respectively, could be detected with a 5% false-positive rate and that 1 in 5 pregnancies classified as being screen positive would develop pregnancy hypertension. This method of screening is far superior to the traditional approach, which relies entirely on maternal history.
Comment in
-
First-trimester prediction of early preeclampsia: a possibility at last!Hypertension. 2009 May;53(5):747-8. doi: 10.1161/HYPERTENSIONAHA.109.129379. Epub 2009 Mar 9. Hypertension. 2009. PMID: 19273735 Free PMC article. No abstract available.
Similar articles
-
Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.Ultrasound Obstet Gynecol. 2008 Nov;32(6):732-9. doi: 10.1002/uog.6244. Ultrasound Obstet Gynecol. 2008. PMID: 18956425
-
Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia.J Hum Hypertens. 2013 Feb;27(2):115-8. doi: 10.1038/jhh.2012.1. Epub 2012 Feb 16. J Hum Hypertens. 2013. PMID: 22336906
-
Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.Prenat Diagn. 2009 Dec;29(12):1103-8. doi: 10.1002/pd.2375. Prenat Diagn. 2009. PMID: 19777530
-
First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort.Ultrasound Obstet Gynecol. 2014 Sep;44(3):279-85. doi: 10.1002/uog.13435. Epub 2014 Aug 13. Ultrasound Obstet Gynecol. 2014. PMID: 24913190 Review.
-
First-trimester maternal factors and biomarker screening for preeclampsia.Prenat Diagn. 2014 Jul;34(7):618-27. doi: 10.1002/pd.4397. Epub 2014 May 21. Prenat Diagn. 2014. PMID: 24764257 Review.
Cited by
-
First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth.Placenta. 2013 Jan;34(1):14-9. doi: 10.1016/j.placenta.2012.10.013. Epub 2012 Nov 28. Placenta. 2013. PMID: 23199792 Free PMC article.
-
Dealing with Pheochromocytoma during the First Trimester of Pregnancy.Case Rep Obstet Gynecol. 2015;2015:439127. doi: 10.1155/2015/439127. Epub 2015 Mar 8. Case Rep Obstet Gynecol. 2015. PMID: 25838955 Free PMC article.
-
Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns.J Pregnancy. 2018 Jun 28;2018:2632637. doi: 10.1155/2018/2632637. eCollection 2018. J Pregnancy. 2018. PMID: 30050697 Free PMC article. Review.
-
Prognostic risk factors for early diagnosing of Preeclampsia in Nulliparas.Niger Med J. 2013 Sep;54(5):344-8. doi: 10.4103/0300-1652.122368. Niger Med J. 2013. PMID: 24403715 Free PMC article.
-
First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.Placenta. 2011 Apr;32(4):333-8. doi: 10.1016/j.placenta.2011.01.016. Epub 2011 Feb 13. Placenta. 2011. PMID: 21324404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical